What Eli Lilly Gets With CoLucid Acquisition
This acquisition not only will enhance Eli Lilly's existing portfolio in pain management for migraine, but it also adds a potential near-term launch to its late-stage pipeline.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 179
What the FDA Approves — and What It Doesn’t
A product advertised as "FDA-approved" may or may not have been approved by the agency, and, as in almost all marketplace decisions, it's buyer beware of these claims.
Tuesday’s Top Biopharma Movers
A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off.
UnitedHealth Takes Aim at New 52-Week High After Solid Earnings
UnitedHealth Group beats earnings, revenue estimates; on track for new 52-week high.
Merck Is Best Performing DJIA Stock So Far in 2017
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
Thursday’s Biggest Biopharma Winners
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. At first 2017 seemed like it could be different for this sector,…
Why 3 Analysts Upgraded Merck Simultaneously
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
America’s 400 Richest Taxpayers Could Get $7 Million Tax Cuts If ACA Is Repealed
Obamacare repeal would add $7 million to the annual income of America's 400 richest taxpayers.
Major Pharma Short Interest Declines Ahead of Trump Comments
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.
Biotech Short Sellers Run for Cover
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
Wednesday’s Top Biopharma Movers
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and a slight…
Tuesday’s Top Biopharma Movers
Considering the new Trump administration, there is an increasingly positive sentiment in the health care sector. In the past year, the health care sector was in trouble under fire from congressional hearings and politicians…
Why Valeant Is Making a Run
Valeant Pharmaceuticals made waves early on Tuesday after the company offered announcements of a late-stage psoriasis trial and the sale of a couple business segments.
Jefferies Has 5 Top Biotech Stocks to Buy for 2017
Needless to say, the past two years have been rough on biotech. The question for investors is which of the stocks hold the best potential in 2017.
Monday’s Merger That No One Saw Coming
Mergers and acquisitions are a way for companies to come together and complement each other’s business models. However, one acquisition stood out on Monday that had some investors scratching their heads.